Leading our project teams to address the specific needs of each of our clients, VCLS Senior Consultants provide their expertise in the regulatory, medical and strategic domains, while maintaining personal contacts with the regulatory agencies.

Senior Expert Team

Gopalan Narayanan, M.D.

Vice President, Disruptive Biologics

Gopalan Narayanan, M.D.

Vice President, Disruptive Biologics

Dr. Narayanan has extensive experience in the assessment of MAAs and provision of advice at UK MHRA, where he spent for 16 years as an expert medical assessor and as Manager of the Biologicals Unit. He has in-depth...



Valérie Pimpaneau, Ph.D.

Vice President, CMC & Quality

Valérie Pimpaneau, Ph.D.

Vice President, CMC & Quality

Valerie Pimpaneau is responsible for the management of projects involving the development of CMC, bio-analytical and quality strategies for Drugs, Biologics, Gene and Cell Therapy.



Eric Wéry, BNSc, MPH, MHSc, MBA

Vice President – Market Access

Eric Wéry, BNSc, MPH, MHSc, MBA

Vice President – Market Access

Responsible for assisting international clients understand the early implications of evidence for access considerations.



Frédéric Pailloux, Pharm.D. M.Sc.

Senior Director, Regulatory Science, Drugs & Biologics

Frédéric Pailloux, Pharm.D. M.Sc.

Senior Director, Regulatory Science, Drugs & Biologics

Frederic Pailloux manages projects involving the design and implementation of global regulatory strategies for the development, evaluation and marketing of small molecules and biologics.



Florence Bine-Scheck, MD

Senior Medical Director

Florence Bine-Scheck, MD

Senior Medical Director

As Senior Medical Director with VCLS, Florence is Head of the Non Clinical and Clinical Development group.



Marie Deneux, Ph.D.

Senior Director, Regulatory Science, Drugs & Biologics

Marie Deneux, Ph.D.

Senior Director, Regulatory Science, Drugs & Biologics

Marie has extensive experience in interactions with the EMA, national European Health Authorities, especially in coordinating SME meetings, Scientific Advice Request/Protocol Assistance/Parallel Scientific Advice. 



Christophe Amiel, M.Sc.

Senior Director, Medical Devices & Digital Life Sciences

Christophe Amiel, M.Sc.

Senior Director, Medical Devices & Digital Life Sciences

Christophe Amiel is heading the design and implementation of regulatory strategy as Senior Director within Voisin Consulting Life Sciences.



Marielle Fournier, Pharm.D.

Senior Director, Drugs, Devices & Combination Products

Marielle Fournier, Pharm.D.

Senior Director, Drugs, Devices & Combination Products

Marielle has several responsibilities within the management of projects involving the design and implementation of global regulatory strategies.



David Lucking, B.Sc.

Senior Director, Regulatory Science, Drugs & Biologics

David Lucking, B.Sc.

Senior Director, Regulatory Science, Drugs & Biologics

David Lucking is currently Senior Director, Regulatory Science, Drugs and Biologics at Voisin Consulting Life Sciences.



Mark Gauthier

Senior Director, Regulatory Science, Drugs & Biologics

Mark Gauthier

Senior Director, Regulatory Science, Drugs & Biologics

Mark is responsible for assisting clients to define the regulatory strategies for the global development and registration of drugs, biologics & cell and gene therapy products.



Michael Husband

Director, Medical Devices and Combination Products

Michael Husband

Director, Medical Devices and Combination Products

As Director, Medical Devices and Combination Products, Michael works with clients on the design and implementation of the regulatory strategy for their devices and products. 



Chris Wilson, B.Sc., M.Sc., MTOPRA

Senior Director, Drugs & Biologics

Chris Wilson, B.Sc., M.Sc., MTOPRA

Senior Director, Drugs & Biologics

As Senior Director, Chris manages the design and implementation of global regulatory strategies for the development, evaluation and marketing of small molecules and biologics.



Carlo Chiavaroli, Ph.D

Director, Nonclinical & Early Clinical Development

Carlo Chiavaroli, Ph.D

Director, Nonclinical & Early Clinical Development

With 20 years in diverse areas of the pharmaceutical industry, Dr. Carlo Chiavaroli has considerable expertise in the drug development process.



Delphine Kazancigil, Pharm.D, M.Sc

Director, Regulatory Science, Drugs & Biologics

Delphine Kazancigil, Pharm.D, M.Sc

Director, Regulatory Science, Drugs & Biologics

Delphine is an experienced regulatory science professional who has an in-depth knowledge of the European (EU) legislation and regulatory requirements.



Emmanuel Prades, M.Sc.

Director, Clinical Operations

Emmanuel Prades, M.Sc.

Director, Clinical Operations

With 20 years in diverse areas of the pharmaceutical industry, Emmanuel Prades has considerable expertise in project management for the clinical operations processes.



Sylvie Le Glédic, Ph.D.

Director, Medical Devices & IVD

Sylvie Le Glédic, Ph.D.

Director, Medical Devices & IVD

Sylvie Le Glédic is in charge of the design and implementation of global regulatory strategies for the development and registration of in vitro diagnostics medical devices (IVDs).



Elaine O’Callaghan

Director, Regulatory Support

Elaine O’Callaghan

Director, Regulatory Support

Elaine O’Callaghan is head of ePublishing within VCLS and responsible for the Global ePublishing team.  



Alexandra Beumer Sassi, PhD, RAC

Director, CMC

Alexandra Beumer Sassi, PhD, RAC

Director, CMC

As a Director, Chemistry, Manufacturing and Controls at VCLS, Alexandra (Alex) is responsible for providing CMC and regulatory consulting services to clients.



Susan Carter, M.Sc.

Director, Regulatory Science

Susan Carter, M.Sc.

Director, Regulatory Science

As a Director, Regulatory Science, Susan provides scientific and regulatory advice to clients for the development of small molecules and biologics particularly with regards to rare diseases.



Cécile F. Rousseau, Ph.D.

Director

Cécile F. Rousseau, Ph.D.

Director

At VCLS, Cécile is involved in the nonclinical and clinical areas, her expertise encompassing medical devices, cellular therapy, gene therapy, and in vitro diagnostics.



Cécile Henrot, M.Sc.

Director, Regulatory Clinical Trials

Cécile Henrot, M.Sc.

Director, Regulatory Clinical Trials

Cécile Henrot specializes in clinical trials within VCLS, and manages the submissions to European competent authorities, ethics committees and other regulatory bodies as appropriate.



Emmanuelle Sabbah-Petrover, Ph.D.

Director, Complex Biologics

Emmanuelle Sabbah-Petrover, Ph.D.

Director, Complex Biologics

As Associate Director at Voisin Consulting Life Sciences, Emmanuelle manages projects involving cell, gene & tissue-based medicinal products (“ATMPs”); from non-clinical to clinical phases, both in Europe & the US.



Nicolas Martin, M.Sc.

Director, Vigilance Operations

Nicolas Martin, M.Sc.

Director, Vigilance Operations

Nicolas co-heads the Vigilance Operations, to support in managing the group strategy and resources, overseeing QA activities, business development and knowledge management.



Valerie Arnaudinaud-Lignier, Ph.D.

Director, CMC & Quality

Valerie Arnaudinaud-Lignier, Ph.D.

Director, CMC & Quality

Valerie Anaudinaud-Lignier is responsible for the management of projects involving the development of Chemistry Manufacturing and Controls (CMC).



Gabrielle Nayroles, MSc

Director, Market Access

Gabrielle Nayroles, MSc

Director, Market Access

As a Market Access Director at Voisin Consulting Life Sciences (VCLS), Gabrielle works in close collaboration with life science companies and her VCLS colleagues to provide market access strategic insight.